Neuromodulation trials

Add-On ZIDA Sock Therapy for Overactive Bladder

RecruitingNCT07432659Phase: NAStarted 2026-04-17

Summary

Many people with overactive bladder (OAB) continue to experience symptoms despite pharmacologic treatment. This study evaluates the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable d

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Locations

Rutledge Tower at Medical University of South CarolinaCharleston, South Carolina, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07432659